» Articles » PMID: 4124894

Asbestos and Laryngeal Carcinoma

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1973 Aug 25
PMID 4124894
Citations 28
Authors
Affiliations
Soon will be listed here.
Citing Articles

Global, regional and national burden and trends of larynx cancer among adults aged 55 and older from 1990 to 2021: results from the global burden of disease study 2021.

Liao L, Wang H, Cui W, Zhang Q, He X, Wang L BMC Public Health. 2025; 25(1):906.

PMID: 40050798 PMC: 11887261. DOI: 10.1186/s12889-025-21993-0.


Integrating GEO, network pharmacology, and in vitro assays to explore the pharmacological mechanism of Bruceae Fructus against laryngeal cancer.

Wu Z, Zhu Z, Fu L Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(6):4165-4181.

PMID: 38032489 PMC: 11111496. DOI: 10.1007/s00210-023-02869-9.


Trend and projection of larynx cancer incidence and mortality in China from 1990 to 2044: A Bayesian age-period-cohort modeling study.

Ye E, Huang J, Wang J, Zhao Y, Niu D, Liu J Cancer Med. 2023; 12(15):16517-16530.

PMID: 37306154 PMC: 10469639. DOI: 10.1002/cam4.6239.


The Role of Polymorphisms and Serum IL-9 Levels in Carcinogenesis and Survival Rate for Laryngeal Squamous Cell Carcinoma.

Pasvenskaite A, Liutkeviciene R, Gedvilaite G, Vilkeviciute A, Liutkevicius V, Uloza V Cells. 2021; 10(3).

PMID: 33803218 PMC: 8001846. DOI: 10.3390/cells10030601.


Impact of Promoter Polymorphisms and IL-10 Serum Levels on Advanced Laryngeal Squamous Cell Carcinoma and Survival Rate.

Pasvenskaite A, Liutkeviciene R, Gedvilaite G, Vilkeviciute A, Liutkevicius V, Uloza V Cancer Genomics Proteomics. 2021; 18(1):53-65.

PMID: 33419896 PMC: 7796822. DOI: 10.21873/cgp.20241.